Fc-dependent depletion of tumor-infiltrating regulatory t cells co-defines the efficacy of anti-CTLA-4 therapy against melanoma Journal Article


Authors: Simpson, T. R.; Li, F.; Montalvo Ortiz, W.; Sepulveda, M. A.; Bergerhoff, K.; Arce, F.; Roddie, C.; Henry, J. Y.; Yagita, H.; Wolchok, J. D.; Peggs, K. S.; Ravetch, J. V.; Allison, J. P.; Quezada, S. A.
Article Title: Fc-dependent depletion of tumor-infiltrating regulatory t cells co-defines the efficacy of anti-CTLA-4 therapy against melanoma
Abstract: Treatment with monoclonal antibody specific for cytotoxic T lymphocyte-associated antigen 4 (CTLA-4), an inhibitory receptor expressed by T lymphocytes, has emerged as an effective therapy for the treatment of metastatic melanoma. Although subject to debate, current models favor a mechanism of activity involving blockade of the inhibitory activity of CTLA-4 on both effector (T eff) and regulatory (T reg) T cells, resulting in enhanced antitumor effector T cell activity capable of inducing tumor regression. We demonstrate, however, that the activity of anti-CTLA-4 antibody on the T reg cell compartment is mediated via selective depletion of T reg cells within tumor lesions. Importantly, T reg cell depletion is dependent on the presence of Fc? receptor-expressing macrophages within the tumor microenvironment, indicating that T reg cells are depleted in trans in a contextdependent manner. Our results reveal further mechanistic insight into the activity of anti-CTLA-4-based cancer immunotherapy, and illustrate the importance of specific features of the local tumor environment on the final outcome of antibody-based immunomodulatory therapies © 2013 Simpson et al.
Journal Title: Journal of Experimental Medicine
Volume: 210
Issue: 9
ISSN: 0022-1007
Publisher: Rockefeller University Press  
Date Published: 2013-08-26
Start Page: 1695
End Page: 1710
Language: English
DOI: 10.1084/jem.20130579
PROVIDER: scopus
PMCID: PMC3754863
PUBMED: 23897981
DOI/URL:
Notes: --- - Cited By (since 1996):1 - "Export Date: 1 October 2013" - "CODEN: JEMEA" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Jedd D Wolchok
    905 Wolchok